Schroder Investment Management Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-84,800
| Closed | -$6.46M | – | 1358 |
|
|
2019
Q3 | $6.46M | Buy |
84,800
+18,500
| +28% | +$1.41M | 0.01% | 709 |
|
|
2019
Q2 | $5.66M | Buy |
66,300
+12,600
| +23% | +$1.08M | 0.01% | 674 |
|
|
2019
Q1 | $5.8M | Buy |
+53,700
| New | +$5.8M | 0.01% | 676 |
|
|
2018
Q3 | – | Sell |
-24,416
| Closed | -$2.81M | – | 1348 |
|
|
2018
Q2 | $2.81M | Sell |
24,416
-233,504
| -91% | -$26.9M | ﹤0.01% | 793 |
|
|
2018
Q1 | $25.5M | Sell |
257,920
-168,535
| -40% | -$16.6M | 0.04% | 404 |
|
|
2017
Q4 | $44.7M | Sell |
426,455
-135,983
| -24% | -$14.2M | 0.07% | 312 |
|
|
2017
Q3 | $62.9M | Sell |
562,438
-118,804
| -17% | -$13.3M | 0.11% | 235 |
|
|
2017
Q2 | $76.6M | Sell |
681,242
-43,260
| -6% | -$4.86M | 0.14% | 187 |
|
|
2017
Q1 | $87.2M | Sell |
724,502
-105,139
| -13% | -$12.7M | 0.16% | 177 |
|
|
2016
Q4 | $87.3M | Sell |
829,641
-38,578
| -4% | -$4.06M | 0.17% | 156 |
|
|
2016
Q3 | $95.9M | Buy |
868,219
+32,100
| +4% | +$3.55M | 0.18% | 134 |
|
|
2016
Q2 | $122M | Buy |
836,119
+142,051
| +20% | +$20.7M | 0.24% | 99 |
|
|
2016
Q1 | $98.5M | Buy |
694,068
+295,727
| +74% | +$42M | 0.2% | 121 |
|
|
2015
Q4 | $61.6M | Buy |
398,341
+95,637
| +32% | +$14.8M | 0.13% | 193 |
|
|
2015
Q3 | $43.3M | Buy |
302,704
+289,604
| +2,211% | +$41.4M | 0.09% | 275 |
|
|
2015
Q2 | $1.86M | Buy |
+13,100
| New | +$1.86M | ﹤0.01% | 840 |
|
|
2014
Q4 | – | Sell |
-286,038
| Closed | -$44M | – | 1502 |
|
|
2014
Q3 | $44M | Sell |
286,038
-24,762
| -8% | -$3.81M | 0.06% | 306 |
|
|
2014
Q2 | $43.6M | Buy |
+310,800
| New | +$43.6M | 0.05% | 305 |
|